Official Blog of © The Horse Fund
BY JANE ALLIN The story of the quest for a generic Premarin is an interesting one – one that dates back to the mid 1980’s when the FDA announced that Premarin was effective in combating the bone loss associated with osteoporosis. To this day an Abbreviated New Drug Application (ANDA) for a generic version has… Continue reading The Quest for a Generic Premarin – A Bitter Pill to Swallow
Newest Member of the Premarin Family ― Duavee How will this new drug impact profits and inevitably the PMU mares and their foals? DUAVEE®, the Premarin® ― bazedoxifene combination therapy for the treatment of menopausal symptoms and prevention of postmenopausal osteoporosis in women who have not undergone hysterectomy was FDA-approved in October 2013 amid speculation… Continue reading Premarin Horses: How many does it take to make a billion dollars? Part 3
by JANE ALLIN News of the FDA’s approval of Pfizer’s new combination drug – DUAVEE® – for the treatment of menopausal symptoms and prevention of osteoarthritis has traveled fast around the globe as have the myths surrounding it. An online article originating in the UK is riddled with untruths and outright lies claiming that DUAVEE®… Continue reading Say no to Pfizer’s DUAVEE® and yes to safer alternatives
With concerns about risks associated with conventional hormone replacement therapy (HRT) manufactured from the urine of pregnant mares (i.e. Premarin®, Prempro®) Depomed Inc., a specialty pharmaceutical company headquartered in Newark, California, submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) on July 31, 2012 for Serada™ – an extended time… Continue reading FDA rejects possible Premarin replacement drugs
As a new generation of women approach menopause, will the HRT lessons of the 1970s and 2000's be lost amid Pharma's marketing again? Martha Rosenberg has been writing intelligently and cohesively about the issues surrounding the Premarin® family of drugs for a good while, and we are very grateful to her. Rosenberg has penned another… Continue reading Will women have short memories about HRT? Pharma hopes so
by JANE ALLIN Int'l Fund for Horses Special Report PART 2, THE MONEY THE primary intent of this article was not to expound on the pros and cons of Salix but rather to focus on the aspect of greed and money that is synonymous with the North American racing industry. A South African project undertaken… Continue reading Blood Money: Salix and Beyond – Part 2, the Money
"If anyone believes that the downsizing of the PMU industry here in North America is advantageous for the mares and foals who suffer at the hands of Big Pharma, they are sadly mistaken" -- Jane Allin The news in January 2009 of pharmaceutical giant Pfizer’s announcement to take over rival company Wyeth for $68 billion… Continue reading Pfizer consigns PMU horses to killing fields of Asia
UPDATE: Aprela approved by the FDA during last federal government shutdown under the name Duavee. Written by JANE ALLIN Pfizer’s recent announcement to seek U.S. regulatory approval for their combined menopausal-osteoporosis drug Aprela® is nothing short of an appalling money grab and a ruse to defer negative focus from their controversial hormone-replacement therapies – Prempro®… Continue reading Pfizer’s love affair with carcinogens continues with Aprela®
by JANE ALLIN The year 2010 saw the reduction in the number of farms in the North American PMU industry dwindle to a mere 26 ranches housing approximately 40 horses each. This is a far cry from the once prolific industry that flourished in Manitoba, Saskatchewan and North Dakota where at the peak of its… Continue reading Where are the PMU farms?
Tuesday's Horse 